4.7 Review

The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies

Journal

MEDICINAL RESEARCH REVIEWS
Volume 41, Issue 1, Pages 202-222

Publisher

WILEY
DOI: 10.1002/med.21729

Keywords

chaperones; diabetic peripheral neuropathy; heat shock response; HSF-1; Hsp90; neurodegeneration; neuropathy

Funding

  1. National Institute of General Medical Sciences [T32GM075762]
  2. National Institutes of Health [CA213586, N5075311]

Ask authors/readers for more resources

Heat shock proteins (Hsps) act as molecular chaperones and are involved in the activation of the heat shock response (HSR) to counter abnormal physiological conditions and stress, potentially helping in conditions such as cancer and neurodegenerative diseases. Cellular stress results in the upregulation of Hsp70 transcription to protect cells, with Hsp90 being the primary regulator of the HSR and a potential target for therapeutic interventions in neuropathies.
Heat shock proteins (Hsps) are molecular chaperones that also play important roles in the activation of the heat shock response (HSR). The HSR is an evolutionary conserved and protective mechanism that is used to counter abnormal physiological conditions, stressors, and disease states, such as those exemplified in cancer and/or neurodegeneration. In normal cells, heat shock factor-1 (HSF-1), the transcription factor that regulates the HSR, remains in a dormant multiprotein complex that is formed upon association with chaperones (Hsp90, Hsp70, etc.), co-chaperones, and client proteins. However, under cellular stress, HSF-1 dissociates from Hsp90 and induces the transcriptional upregulation of Hsp70 to afford protection against the encountered cellular stress. As a consequence of both peripheral and central neuropathies, cellular stress occurs and results in the accumulation of unfolded and/or misfolded proteins, which can be counterbalanced by activation of the HSR. Since Hsp90 is the primary regulator of the HSR, modulation of Hsp90 by small molecules represents an attractive therapeutic approach against both peripheral and central neuropathies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available